Guest: Mesoblast founder Silviu Itescu

Original air date: March 9, 2022

ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.

Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming.

Update: Mesoblast's share price increased by 50% in just one day this week after the US FDA gave the green light to another one of its treatments.

Find out more: https://fearandgreed.com.au/

See omnystudio.com/listener for privacy information.

357: SLC 2012 Conference Pt. 2 - Andrew Ainsworth and Peter Breinholt